Literature DB >> 1190833

[Mitogenic activity of melanoma extracts in leucocyte cultures (author's transl)].

G Lischka.   

Abstract

From a mixed cell suspension of five primary melanomas an aqueous sterile extract was made and added to homologue leucocyte cultures of eight melanoma patients and seven controls. The extract had a blastogenic and mitogenic effect in all cultures. There was no significant difference between the responses of patients and controls. In experiments with an equally prepared extract of normal skin, added to homologue leucocyte cultures of nine persons, none but one had a positive reaction. This indicates, that the motigenic principle of the melanoma extract is not related to the histocompatibility antigen nor caused by chemical or bacterial contamination of the primary cell suspensions. It seems to be derived from the cytoplasmic fraction of melanoma cells. Other experiments to solve the problem were impossible because of lack of material. There are several reports in the literature which by using different methods indicate, that there might be an immunological reaction to melanoma associated principles in healthy persons, too.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1190833     DOI: 10.1007/bf00582062

Source DB:  PubMed          Journal:  Arch Dermatol Res            Impact factor:   3.017


  30 in total

Review 1.  [Immunology of melanoma].

Authors:  R Vanwijck; J L Bernheim; F J Lejeune
Journal:  Acta Chir Belg       Date:  1974-03       Impact factor: 1.090

2.  Demonstration of cell-mediated immunity to human neoplasms of various histological types.

Authors:  I Hellström; K E Hellström; H O Sjögren; G A Warner
Journal:  Int J Cancer       Date:  1971-01-15       Impact factor: 7.396

3.  In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.

Authors:  U W Jehn; L Nathanson; R S Schwartz; M Skinner
Journal:  N Engl J Med       Date:  1970-08-13       Impact factor: 91.245

4.  Demonstration of antibodies against human malignant melanoma by immunofluorescence.

Authors:  D L Morton; R A Malmgren; E C Holmes; A S Ketcham
Journal:  Surgery       Date:  1968-07       Impact factor: 3.982

5.  Cell-mediated immunity in patients with malignant melanoma.

Authors:  R M Mackie; W G Spilg; C E Thomas; A J Cochran
Journal:  Br J Dermatol       Date:  1972-12       Impact factor: 9.302

6.  Lymphocyte stimulation by soluble human HL-A transplantation antigens.

Authors:  D C Viza; O Degani; J Dausset; D A Davies
Journal:  Nature       Date:  1968-08-17       Impact factor: 49.962

7.  Cellular and humoral immunity against human malignant melanoma.

Authors:  G Fossati; M I Colnaghi; G D Porta; N Cascinelli; U Veronesi
Journal:  Int J Cancer       Date:  1971-09-15       Impact factor: 7.396

8.  A colony inhibition (CI) technique for demonstration of tumor cell destruction by lymphoid cells in vitro.

Authors:  I Hellström
Journal:  Int J Cancer       Date:  1967-01-15       Impact factor: 7.396

9.  [Significance of histological findings in the prognosis of malignant melanoma. Findings in 253 melanoma patients followed for 5 years].

Authors:  H Gartmann; H Tritsch
Journal:  Dtsch Med Wochenschr       Date:  1972-06-02       Impact factor: 0.628

10.  Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.

Authors:  A J Cochran; W G Spilg; R M Mackie; C E Thomas
Journal:  Br Med J       Date:  1972-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.